Is serum cystatin C a better marker of kidney function than serum creatinine in septic newborns?

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0

Abstract

[sub][/sub] Introduction: Several studies have claimed that the estimation of serum cystatin C could be a better marker of kidney excretory function than serum creatinine. However, its role in the diagnosis of reduced kidney function was not unquestionably confirmed. The aim of this study was to analyze the concentrations of serum cystatin C in neonates with sepsis. Material/Methods: Thirty-two neonates (gestational age from 34 to 40 weeks) admitted to the NICU during the first 14 days of life were enrolled. Serum cystatin C concentrations were estimated by ELISA during three successive days in neonates treated for infection. The study group consisted of 9 newborns with sepsis, 14 with severe sepsis and 9 with septic shock. Results/Discussion: At the beginning of the observational period the mean serum concentration of cystatin C in the study group was 1.35 mg/L (95% CI 1.20–1.49). Surprisingly, the lowest concentration of cystatin was observed in patients with septic shock (1.23 mg/L; 95%CI 0.92–1.54) within the observation period. Higher concentrations were found in neonates with sepsis (1.47 mg/L; 95%CI 1.04–1.90) and severe sepsis (1.50; 1.12–1.87). There was no correlation between serum cystatin C concentration and serum creatinine or gestational age. A significant correlation was discovered between chronological age and cystatin C (R=–0.439, p=0.01). There was a tendency for cystatin C to decline during the second observational day in patients with sepsis (to 1.53 mg/L; 95%CI: 1.19–1.86) and severe sepsis (to 1.32 mg/L; 95%CI: 1.07–1.57), while a slight insignificant increase in patient with septic shock (to 1.28 mg/L; 95%CI: 0.88–1.68) was revealed. The interrelation between age and cystatin C concentration disappeared in the following days of stay in the NICU. Even in patients who died in the course of septic shock the observed changes in cystatin C levels were small and did not exceed those of serum creatinine. Conclusions: Cystatin C is not a useful marker of kidney function in neonates with sepsis.

Authors and Affiliations

Iwona Maruniak-Chudek, Teresa Owsianka-Podleśny, Jolanta Wróblewska, Danuta Jadamus-Niebrój

Keywords

Related Articles

The other face of MUC1 protein in cancer progression – the role of MUC1-C subunit

MUC1 is high-molecular-weight glycoprotein which is widely expressed on epithelial cell layers of various organs and is aberrantly overexpressed in most human carcinomas such as breast, ovarian or colon cancer. MUC1 cont...

Hairy roots culture as a source of valuable biopharmaceuticals

Plants have been exploited as a source of medicinal substances for years. Nowadays, achievements of modern science, including molecular biotechnology, allow their huge potential to be utilized. They have become a promisi...

Immune checkpoint‑targeted cancer immunotherapies

Tumor cells may express on their surface various characteristic antigens that can induce antitumor immunity. However, cancer in human body may induce an immunosuppressive microenvironment that limits immune response to i...

Download PDF file
  • EP ID EP66666
  • DOI -
  • Views 187
  • Downloads 0

How To Cite

Iwona Maruniak-Chudek, Teresa Owsianka-Podleśny, Jolanta Wróblewska, Danuta Jadamus-Niebrój (2012). Is serum cystatin C a better marker of kidney function than serum creatinine in septic newborns?. Advances in Hygiene and Experimental Medicine, 66(0), 175-180. https://europub.co.uk./articles/-A-66666